Overall rank by patents
#27,962
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, active 2021–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B05B (SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES).
The verdict
AC holds 9 US patents across 5 technology areas, rank #27,962 of 50,000 tracked assignees.
AC Avalanche, Llc has been granted 9 US utility patents between 2021 and 2024, placing AC Avalanche, Llc at rank #27,962 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.2 claims per patent with primary concentration in B05B (SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES). As a US Corporation, AC Avalanche, Llc is one of the more focused assignees in the PatentsView dataset. By volume, AC sits between ABB Turbo Systems Ag (9 patents, rank #27,958) and ACO Ahlmann SE & Co. KG (9 patents, rank #27,966) - the closest US assignees by grant volume. The composite Innovation Score of 41.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2024, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. AC Avalanche, Llc's 9.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark AC Avalanche, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ABB Turbo Systems AG
9 patents
ABBISKO THERAPEUTICS CO., LTD.
9 patents
ABCLON INC.
9 patents
ABM Italia S.P.A.
9 patents
ACANDIS GMBH & CO. KG
9 patents
ACCURATE MEDICAL THERAPEUTICS LTD.
9 patents
ACD, LLC
9 patents
ACO AHLMANN SE & CO. KG
9 patents
AC AVALANCHE, LLC
9 patents
What this shows AC holds 9 patents at rank #27,962, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,962 in granted patent volume.
Other assignees with the most granted patents in AC's primary technology class.
AC's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 33% higher than 67% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 11.1% |
| 2022 | 2 | 22.2% |
| 2023 | 1 | 11.1% |
| 2024 | 5 | 55.6% |
Top 5 of 5 technology areas
Overall rank by patents
#27,962
Across all tracked assignees
41.4 out of 100
How to use this portfolio
AC's 9 grants land it in the top 33% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.